New Targeted Therapies for HER2-Positive Metastatic Breast Cancer

Gain multidisciplinary perspectives on how to leverage novel and established HER2-targeted agents for optimal mangement of HER2-positive metastatic breast cancer with these downloadable slides from expert-led workshops and Webinars.

Share

Program Content

Activities

HER2 MBC Tx Slides
New Targeted Therapies for HER2-Positive Metastatic Breast Cancer: Downloadable Slides
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: September 23, 2020

Expires: September 22, 2021

Faculty

cover img faculity

Sara Hurvitz, MD

Assistant Professor of Medicine
Director, Breast Oncology Program
Division of Hematology-Oncology
Department of Internal Medicine
David Geffen School of Medicine at UCLA
Los Angeles, California

cover img faculity

Sara M. Tolaney, MD, MPH

Chief, Division of Breast Oncology
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, Massachusetts

Supporters

Supported by educational grants from

AstraZeneca

Daiichi Sankyo, Inc.

Puma Biotechnology, Inc.

Seagen